Loading clinical trials...
Loading clinical trials...
A Phase IV Study to Evaluate Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis (SJIA) Who Experience Laboratory Abnormalities During Treatment With Tocilizumab
Conditions
Interventions
Tocilizumab
Locations
19
United States
Children's Hospital Los Angeles; Division of Rheumatoogy
Los Angeles, California, United States
Cincinnati Children'S Hospital Medical Center; Division of Rheumatology
Cincinnati, Ohio, United States
Hospital Gral de Niños Pedro Elizalde
Buenos Aires, Argentina
Hospital Dr. Humberto Notti
Mendoza, Argentina
Alberta Children'S Hospital
Calgary, Alberta, Canada
Charité Campus; Virchow Klinikum Berlin
Berlin, Germany
Start Date
June 10, 2013
Primary Completion Date
October 9, 2019
Completion Date
October 9, 2019
Last Updated
April 24, 2020
NCT06870045
NCT04902807
NCT04833465
NCT07000916
NCT06007456
NCT05572424
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions